Exploration of the weight neutral effects of insulin detemir compared to insulin glargine: A measure of satiety and calories consumed in type 1 diabetes.

Trial Profile

Exploration of the weight neutral effects of insulin detemir compared to insulin glargine: A measure of satiety and calories consumed in type 1 diabetes.

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Oct 2011

At a glance

  • Drugs Insulin detemir (Primary) ; Insulin glargine
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 04 Oct 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
    • 16 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top